🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This clinical trial studies fludarabine phosphate, low-dose total body irra...
Status
Completed
Location
City of Hope Medical Center
Start Date
1999-11
Trial ID
NCT00005799
Treatments Being Tested
This trial is designed to expand the currently available data on the safety...
Status
Completed
Location
ECOGENE-21 Clinical Trial Center / Centre de santé et de services sociaux de Chicoutimi
Start Date
2009-02
Trial ID
NCT00891306
This is a study of two treatment pathways \[Standard steroid treatment vers...
Status
Completed
Location
University Hospital Bristol NHS Foundation Trust
Start Date
2017-10-25
Trial ID
NCT03156452
Treatments Being Tested
To evaluate the safety of 3 regimens of short-term, low-dose systemic IMT a...
Status
Withdrawn
Location
Wills Eye Institute
Start Date
2015-08-24
Trial ID
NCT02563782
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cell...
Status
Terminated
Location
Rocky Mountain Cancer Centers
Start Date
2001-10
Trial ID
NCT00041288
The purpose of this trial is to examine the benefits of early combination o...
Status
Completed
Location
The Ohio State University Multiple Sclerosis Center
Start Date
2006-08
Trial ID
NCT00618527
Treatments Being Tested
The proposed study is a masked trial, with stratified block randomization b...
Status
Completed
Location
Aravind Eye Hospital
Start Date
2010-10
Trial ID
NCT01232920
Treatments Being Tested
Immunocompromised individuals, such as solid organ transplant (SOT) recipie...
Status
Active Not Recruiting
Location
University of California, Davis
Start Date
2021-09-24
Trial ID
NCT05060991
Treatments Being Tested
Following a transplant for hepatitis C cirrhosis, the infection comes back ...
Status
Terminated
Location
Novartis Investigative Site
Start Date
2006-01
Trial ID
NCT00260208
Treatments Being Tested
This is a phase II trial using a non-myeloablative cyclophosphamide/ fludar...
Status
Completed
Location
Masonic Cancer Center at University of Minnesota
Start Date
2017-03-09
Trial ID
NCT02661035